Clifford Starke - 30 Jun 2025 Form 4 Insider Report for Flora Growth Corp. (FLGC)

Role
CEO, Director
Signature
/s/ Dany Vaiman as attorney-in-fact for Clifford Starke
Issuer symbol
FLGC
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
4
Filing time
02 Jul 2025, 10:55:09 UTC
Previous filing
17 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Starke Clifford CEO, Director C/O FLORA GROWTH CORP., 3230 W. COMMERCIAL BLVD., SUITE 180, FORT LAUDERDALE /s/ Dany Vaiman as attorney-in-fact for Clifford Starke 01 Jul 2025 0001955468

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGC Stock Appreciation Rights ("SARs") Disposed to Issuer -1,028,665 -100% 0 30 Jun 2025 Common Shares 1,028,665 $1.21 Direct F1, F2
transaction FLGC Stock Appreciation Rights ("SARs") Award +1,028,665 1,028,665 30 Jun 2025 Common Shares 1,028,665 $0.5800 Direct F1, F2
transaction FLGC Stock Appreciation Rights ("SARs") Disposed to Issuer -575,319 -100% 0 30 Jun 2025 Common Shares 575,319 $0.9150 Direct F1, F2
transaction FLGC Stock Appreciation Rights ("SARs") Award +575,319 575,319 30 Jun 2025 Common Shares 575,319 $0.5800 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The SARs vest in 9 equal installments, subject to stock price criteria to be met prior to each trance vesting. The SARs have a post-termination exercise period of one year.
F2 The SARs granted to the reporting person on December 15, 2023, and August 14, 2024, were amended, with shareholder approval, to have a lower exercise price.